Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer

Nutrition and Cancer

Volumn 62, Issue 8, 2010, Pages 1074-1086

  De Angel, Rebecca E ^a   Smith, Sarah M ^a   Glickman, Randolph D ^b   Perkins, Susan N ^a   Hursting, Stephen D ^a,c  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; SOMATOMEDIN C; URSOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DIET THERAPY; ENZYME ACTIVITY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; POSTMENOPAUSE; TUMOR NECROSIS; TUMOR VOLUME;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVARIECTOMY; POSTMENOPAUSE; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; TRITERPENES; TUMOR BURDEN;

MOUSE MAMMARY TUMOR VIRUS; MUS;

EID: 78249242752     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.492092     Document Type: Article

References (40)

1. American Cancer Society: Cancer Facts and Figures. Atlanta, GA: American Cancer Society, 2009.
2. Linseisen J, Rohrmann S, Miller AB, Bueno-de-Mesquita HB, Büchner FL, et al.: Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 121, 1103-1114, 2007. (Pubitemid 47101650)
3. Amin A R M R, Kucuk O, Khuri FR, and Shin DM: Perspectives for cancer prevention with natural compounds. J Clin Oncol 27, 2712-2725, 2009.
4. Paterson I and Anderson E: Chemistry: the renaissance of natural products as drug candidates. Science 310, 2005.
5. Altmann K and Gertsch J: Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents. Nat Prod Rep 24, 327-357, 2007.
6. Ikeda Y, Murakami A, and Ohigashi H: Ursolic acid: an anti-and proinflammatory triterpenoid. Mol Nutr Food Res 52, 26-42, 2008.
7. Tang C, Lu Y, Xie J, Wang F, Zou J, et al.: Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acidinduced HepG2 cell apoptosis. Anticancer Drugs 20, 249-258, 2009.
8. Shishodia S, Majumdar S, Banerjee S, and Aggarwal BB: Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of ikappabalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 63, 4375-4383, 2003.
9. Jayaprakasam B, Olson L, Schutzki R, Tai M-H, and Nair M: Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in cornelian cherry (Cornus mas). J Agric Food Chem 54, 243-248, 2006.
10. Wall M: Camptothecin and taxol: discovery to clinic. Med Res Rev 18, 299-314, 1998.
11. Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, et al.: Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res 67, 8396-8405, 2007.
12. Moiseeva E, Almeida G, Jones G, and Manson M: Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther 6, 3071-3079, 2007.
13. van Meeuwen J, Korthagen N, de Jong P, Piersma A, and van den Berg M: (Anti) estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol Appl Pharmacol 221, 372-383, 2007.
14. Tanaka R, Minami T, Ishikawa Y, Matsunaga S, Tokuda H, et al.: Cancer chemopreventive activity of serratane-type triterpenoids on two-stage mouse skin carcinogenesis. Cancer Lett 196, 121-126, 2003. (Pubitemid 36830890)
15. Achiwa Y, Hasegawa K, and Udagawa Y: Regulation of the phosphatidylinositol 3-kinase-Akt and the mitogen-activated protein kinase pathways by ursolic acid in human endometrial cancer cells. Biosci Biotechnol Biochem 71, 31-37, 2007.
16. Novotný L, Vachalkova A, and Biggs D: Ursolic acid: an anti-tumorigenic and chemopreventive activity. Neoplasma 48, 241-246, 2001.
17. Nunez NP, Perkins SN, Smith NC, Berrigan D, Berendes DM, et al.: Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer 60, 534-541, 2008.
18. Li Y, Hively W, and Varmus H: Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19, 1002-1009, 2000.
19. Huang Y, Li J, Wang R, Wu Q, Li Y, et al.: Effect of triterpene acids of Eriobotrya japonica (Thunb.) Lindl. leaf on inflammatory cytokine and mediator induction from alveolar macrophages of chronic bronchitic rats. Inflamm Res 56, 76-82, 2007.
20. Miceli N, Taviano M, Giuffrida D, Trovato A, Tzakou O, et al.: Antiinflammatory activity of extract and fractions from Nepeta sibthorpii Bentham. J Ethnopharmacol 97, 261-266, 2005.
21. Huang M-T, Ho C-T, Wang ZY, Ferraro T, Lou Y-R, et al.: Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 54, 701-708, 1994.
22. De Angel R, Berrigan D, Núñez N, Hursting S, and Perkins S: Dietary calcium source influences body composition, glucose metabolism and hormone levels in a mouse model of postmenopausal obesity. In Vivo 23, 527-535, 2009.
23. Jelovac D, Macedo L, Handratta V, Long BJ, Goloubeva OG, et al.: Effects of exemestane and tamoxifen in a postmenopausal breast cancer model. Clin Cancer Res 10, 7375-7381, 2004.
24. Moore T, Carbajal S, Beltran L, Perkins SN, Yakar S, et al.: Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels. Cancer Res 68, 3680-3688, 2008.
25. Svirshchevskaya E, Mariotti J, Wright M, Viskova N, Telford W, et al.: Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity. BMC Cancer 8, 176, 2008.
26. Gellert G, Dikmen Z, Wright W, Gryaznov S, and Shay J: Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer. Breast Cancer Res Treat 96, 73-81, 2006.
27. Ross S: Peirce's criterion for the elimination of suspect experimental data. J Eng Tech 2, 1-11, 2003.
28. Kanamori A, Nakamura M, Nakanishi Y, Nagai A, Mukuno H, et al.: Akt is activated via insulin/IGF-1 receptor in rat retina with episcleral vein cauterization. Brain Res 1022, 195-204, 2004.
29. Balmanno K and Cook S: Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18, 3085-3097, 1999.
30. Cárdenas C, Quesada AR, and Medina MÁ: Effects of ursolic acid on different steps of the angiogenic process. Biochem Biophys Res Commun 320, 402-408, 2004.
31. Lee H, Chung H, Kim K, Lee J, and Kim K: Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J Cancer Res Clin Oncol 120, 513-518, 1994.
32. Kiran M, Kumar V, Viji R, Sherin G, Rajasekharan K, et al.: Opposing effects of curcuminoids on serum stimulated and unstimulated angiogenic response. J Cell Physiol 215, 251-264, 2008.
33. Kousidou O, Tzanakakis G, and Karamanos N: Effects of the natural isoflavonoid genistein on growth, signaling pathways and gene expression of matrix macromolecules by breast cancer cells. Mini Rev Med Chem 6, 331-337, 2006.
34. He X and Liu RH: Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple's anticancer activity. J Agric Food Chem 55, 4366-4370, 2007.
35. Sgroi D: Transition from normal breast tissue to ductal carcinoma in sity. Section on Frontiers in Cancer Prevention-AACR, Houston, TX, 2009.
36. Calle EE and Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4, 579-591, 2004.
37. Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, et al.: Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim Biophys Acta 1760, 1505-1512, 2006.
38. Jung S, Ha Y, Shim E, Choi S, Jin J, et al.: Insulin-mimetic and insulinsensitizing activities of a pentacyclic triterpenoid insulin receptor activator. Biochem J 403, 243-250, 2007.
39. Renehan A, Roberts D, and Dive C: Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114, 71-83, 2008.
40. Coussens LM and Werb Z: Inflammation and cancer. Nature 420, 860-867, 2002.